Literature DB >> 29217406

LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.

Yuan Chen1, Ya-Jun Lian2, Yun-Qing Ma1, Chuan-Jie Wu1, Ya-Ke Zheng1, Nan-Chang Xie1.   

Abstract

Numerous long non-coding RNAs (lncRNAs) have been identified as aberrantly expressed in Parkinson's disease (PD). However, limited knowledge is available concerning the roles of dysregulated lncRNAs and the underlying molecular regulatory mechanism in the pathological process of PD. In this study, we found that lncRNA small nucleolar RNA host gene 1 (SNHG1) and seven in absentia homolog 1 (SIAH1) were upregulated, but microRNA-15b-5p (miR-15b-5p) was downregulated in SH-SY5Y cells pretreated with MPP+, as well as in MPTP-induced mouse model of PD. Overexpression of SIAH1 enhanced cellular toxicity of α-synuclein in SH-SY5Y cells, as indicated by the reduction of cell viability and elevation of LDH release. The percentage of α-synuclein aggregate-positive cells and the number of α-synuclein aggregates per cell were increased in SH-SY5Y cells transfected with pcDNA-SIAH1, while decreased after transfection with short interfering RNA specific for SIAH1 (si-SIAH1). Bioinformatics and luciferase reporter assay revealed that SIAH1 was a direct target of miR-15b-5p. We also found that SNHG1 could directly bind to miR-15-5p and repress miR-15-5p expression. Upregulation of miR-15b-5p alleviated α-synuclein aggregation and apoptosis by targeting SIAH1 in SH-SY5Y cells overexpressing α-synuclein. Overexpression of SNHG1 enhanced, whereas SNHG1 knockdown inhibited α-synuclein aggregation and α-synuclein-induced apoptosis. Moreover, the neuroprotective effect of si-SNHG1 was abrogated by downregulation of miR-15b-5p. In summary, our data suggest that SNHG1, as a pathogenic factor, promotes α-synuclein aggregation and toxicity by targeting the miR-15b-5p/SIAH1 axis, contributing to a better understanding of the mechanisms of Lewy body formation and loss of dopaminergic neurons in PD.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  SIAH1; lncRNA SNHG1; miR-15b-5p; α-synuclein

Mesh:

Substances:

Year:  2017        PMID: 29217406     DOI: 10.1016/j.neuro.2017.12.001

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  38 in total

Review 1.  Long Non-coding RNAs in Parkinson's Disease.

Authors:  Chengqi Xin; Jing Liu
Journal:  Neurochem Res       Date:  2021-02-05       Impact factor: 3.996

Review 2.  The Expanding Regulatory Mechanisms and Cellular Functions of Long Non-coding RNAs (lncRNAs) in Neuroinflammation.

Authors:  Shraddha Tripathi; Bakhya Shree; Stuti Mohapatra; Anirban Basu; Vivek Sharma
Journal:  Mol Neurobiol       Date:  2021-02-08       Impact factor: 5.590

Review 3.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

4.  A positive feedback regulation between long noncoding RNA SNHG1 and YAP1 modulates growth and metastasis in laryngeal squamous cell carcinoma.

Authors:  Ling Gao; Hua Cao; Xiulian Cheng
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

Review 5.  A putative role for lncRNAs in epigenetic regulation of memory.

Authors:  Ashleigh B Irwin; Rudhab Bahabry; Farah D Lubin
Journal:  Neurochem Int       Date:  2021-09-14       Impact factor: 3.921

Review 6.  Exosomal long noncoding RNAs - the lead thespian behind the regulation, cause and cure of autophagy-related diseases.

Authors:  Sougata Ghosh Chowdhury; Debalina Bhattacharya; Parimal Karmakar
Journal:  Mol Biol Rep       Date:  2022-06-02       Impact factor: 2.742

Review 7.  Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease.

Authors:  Yuqing Liu; Xin Cheng; Hongli Li; Shan Hui; Zheyu Zhang; Yang Xiao; Weijun Peng
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

8.  Dysregulation of Circulatory Levels of lncRNAs in Parkinson's Disease.

Authors:  Jin-Ying Zhao; Rong-Rong Pan; Teng Jiang; Ting Huang; Xin-Xin Fu; Qing Huang; Xi-Xi Wang; Peng-Yu Gong; You-Yong Tian; Ying-Dong Zhang
Journal:  Mol Neurobiol       Date:  2022-10-20       Impact factor: 5.682

Review 9.  LncRNAs as putative biomarkers and therapeutic targets for Parkinson's disease.

Authors:  Eskandar Taghizadeh; Seyed Mohammad Gheibihayat; Forough Taheri; Seyed Mohammadreza Afshani; Najmeh Farahani; Alihossein Saberi
Journal:  Neurol Sci       Date:  2021-07-12       Impact factor: 3.307

Review 10.  Insights into lncRNAs in Alzheimer's disease mechanisms.

Authors:  Dingfeng Li; Juan Zhang; Xiaohui Li; Yuhua Chen; Feng Yu; Qiang Liu
Journal:  RNA Biol       Date:  2020-07-14       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.